SAM
RPRX icon

Smartleaf Asset Management’s Royalty Pharma RPRX Stock Holding History

Smartleaf Asset Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$94.7K Hold
1,659
– – ﹤0.01% 1198
2026
Q1 		$76.9K Buy
1,659
+254
+18% +$11.1K ﹤0.01% 1243
2025
Q4 		$54.8K Buy
1,405
+524
+59% +$20K ﹤0.01% 1506
2025
Q3 		$31.1K Buy
881
+790
+868% +$28.6K ﹤0.01% 1626
2025
Q2 		$3.26K Sell
91
-283
-76% -$9.38K ﹤0.01% 2183
2025
Q1 		$11.7K Buy
374
+147
+65% +$4.66K ﹤0.01% 1868
2024
Q4 		$5.75K Sell
227
-1,183
-84% -$31.4K ﹤0.01% 2202
2024
Q3 		$39.8K Buy
1,410
+784
+125% +$21.7K ﹤0.01% 995
2024
Q2 		$16.7K Buy
626
+520
+491% +$14.4K ﹤0.01% 1120
2024
Q1 		$3.23K Buy
+106
New +$3.13K ﹤0.01% 1359

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Smartleaf Asset Management's RPRX Position: Q2 2026 in Review

Smartleaf Asset Management held its Royalty Pharma (RPRX) position steady in Q2 2026 at 1,659 shares worth $94.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1198.

Smartleaf Asset Management first reported a position in RPRX in Q1 2024 and has held it in 10 quarters since. 646 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Smartleaf Asset Management held 1,659 shares of Royalty Pharma worth $94.7K as of Q2 2026.
  • Smartleaf Asset Management left its Royalty Pharma share count unchanged in Q2 2026.
  • Royalty Pharma made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #1198 holding.
  • Smartleaf Asset Management first reported a position in Royalty Pharma in Q1 2024 and has held it in 10 quarters since.
  • 646 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.